|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
149,990,000 |
Market
Cap: |
137.98(M) |
Last
Volume: |
394,168 |
Avg
Vol: |
178,875 |
52
Week Range: |
$0.9199 - $0.9199 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lineage Cell Therapeutics is a clinical-stage biotechnology company developing cell therapies. Co. has several allogeneic cell therapy programs in development: OpRegen®, a retinal pigment epithelium cell replacement therapy for the treatment of advanced dry age-related macular degeneration with geographic atrophy; OPC1, an oligodendrocyte progenitor cell therapy for spinal cord injuries; VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells; and other product candidates in preclinical development covering a range of therapeutic areas and target tissues or organs. Co. has rights to HyStem, a patented biomaterial that mimics naturally occurring extracellular matrix.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
10,000 |
6,846,925 |
6,846,925 |
6,846,925 |
Total Buy Value |
$10,500 |
$7,121,402 |
$7,121,402 |
$7,121,402 |
Total People Bought |
1 |
4 |
4 |
4 |
Total Buy Transactions |
1 |
5 |
5 |
5 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Peabody Robert |
Sr. VP, COO, and CFO |
|
2014-07-21 |
4 |
D |
$2.65 |
$237,501 |
D/D |
(89,623) |
415,777 |
|
- |
|
Peabody Robert |
Sr. VP, COO, and CFO |
|
2014-07-21 |
4 |
OE |
$0.50 |
$237,500 |
D/D |
475,000 |
505,400 |
|
- |
|
West Michael D |
Chief Executive Officer |
|
2014-07-21 |
4 |
D |
$2.65 |
$1,150,134 |
D/D |
(434,013) |
1,145,987 |
|
- |
|
West Michael D |
Chief Executive Officer |
|
2014-07-21 |
4 |
OE |
$0.50 |
$735,200 |
D/D |
1,470,400 |
1,580,000 |
|
- |
|
Bradsher Neal C |
Director |
|
2014-06-30 |
4 |
OE |
$2.30 |
$46,000 |
D/D |
20,000 |
62,908 |
|
- |
|
Kingsley Alfred D |
See Remarks |
|
2014-06-27 |
4 |
OE |
$2.30 |
$115,000 |
D/D |
50,000 |
6,038,055 |
|
- |
|
Tew William P Phd |
Chief Commercial Officer |
|
2014-06-17 |
4 |
S |
$3.23 |
$22,610 |
D/D |
(7,000) |
3,265 |
|
- |
|
Bradsher Neal C |
Director |
|
2014-06-16 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
13,422,262 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2014-06-16 |
4 |
B |
$2.50 |
$2,500,000 |
D/D |
1,000,000 |
13,422,262 |
3.92 |
- |
|
Tew William P Phd |
Chief Commercial Officer |
|
2014-06-16 |
4 |
S |
$3.02 |
$60,400 |
D/D |
(20,000) |
10,265 |
|
- |
|
Tew William P Phd |
Chief Commercial Officer |
|
2014-06-13 |
4 |
S |
$2.99 |
$8,970 |
D/D |
(3,000) |
30,265 |
|
- |
|
Bradsher Neal C |
Director |
|
2014-05-16 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
12,422,262 |
2.02 |
- |
|
Bradsher Neal C |
Director |
|
2014-05-16 |
4 |
B |
$2.45 |
$735,000 |
D/D |
300,000 |
12,422,262 |
2.39 |
- |
|
Kingsley Alfred D |
See Remarks |
|
2014-05-16 |
4 |
S |
$2.45 |
$735,000 |
D/D |
(300,000) |
5,988,055 |
|
- |
|
Bradsher Neal C |
Director |
|
2014-05-08 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
12,122,262 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2014-05-08 |
4 |
B |
$2.44 |
$730,500 |
D/D |
300,000 |
12,122,262 |
3.92 |
- |
|
Kingsley Alfred D |
See Remarks |
|
2014-05-08 |
4 |
S |
$2.44 |
$730,500 |
D/D |
(300,000) |
6,288,055 |
|
- |
|
Bradsher Neal C |
Director |
|
2014-05-01 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
11,822,262 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2014-05-01 |
4 |
B |
$2.52 |
$5,040,000 |
D/D |
2,000,000 |
11,822,262 |
3.92 |
- |
|
194 Records found
|
|
Page 8 of 8 |
|
|